<?xml version="1.0" encoding="UTF-8"?>
<p>Although both targeted and opt-out, universal ED-based hepatitis C testing strategies are effective at identifying previously unrecognized HCV infections, reimbursement for testing and challenging HCV infection care navigation remain crucial barriers. A 2014 decision from the U.S. Department of Health and Human Services and Centers for Medicare &amp; Medicaid Services precluding EDs from reimbursement for hepatitis C testing might be limiting adoption of any systematic hepatitis C testing in the majority of EDs.
 <xref ref-type="fn" rid="FN2">
  <sup>â€ </sup>
 </xref> In addition, the high number of persons with HCV infection identified in the ED setting challenges HCV navigation programs and requires robust support to effectively direct persons who test positive to HCV treatment and other necessary health services, including primary care, social services, and substance use treatment.
</p>
